Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
作者
Yan Zhang,Xishan Wu,Xiaoqian Xue,Chenchang Li,Junjian Wang,Rui Wang,cheng Zhang,Chao Wang,Yudan Shi,Lingjiao Zou,Qiu Li,Zenghong Huang,Xiaojuan Hao,Kerry M. Loomes,Donghai Wu,Hongwu Chen,Jinxin Xu,Yong Xu
